Old Web
English
Sign In
Acemap
>
authorDetail
>
Ellen Miles
Ellen Miles
Sunnybrook Health Sciences Centre
Follicular lymphoma
Medicine
Rituximab
Immunology
Neutropenia
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Management of newly diagnosed high‐risk and intermediate‐risk follicular lymphoma with 90Y ibritumomab tiuxetan in a phase II study
2018
Hematological Oncology
Neil Berinstein
Nancy Pennell
Rashmi Weerasinghe
Rena Buckstein
Eugenia Piliotis
Kevin Imrie
Lisa Chodirker
Mary-Anne Cussen
Ellen Miles
Marciano Reis
Zeina Ghorab
Matthew C. Cheung
Show All
Source
Cite
Save
Citations (3)
Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan
2016
Blood
Neil Berinstein
Nancy Pennell
Rashmi Weerasinghe
Matthew C. Cheung
Eugenia Piliotis
Kevin Imrie
Mary-Anne Cussen
Rena Buckstein
Zeina Ghorab
Ellen Miles
Marciano D. Reis
Show All
Source
Cite
Save
Citations (0)
Sustained Immune Competency and Long Term Molecular Remissions in FL Patients with FLIPI Risk Factors >1, Treated Front Line with R-CHOP Followed by Consolidative 90 Y-Radioimmunotherapy and Maintenance Rituximab
2012
Blood
Neil Berinstein
Nancy Pennell
Mary-Anne Cussen
Kevin Imrie
Eugenia Piliotis
Rena Buckstein
Zeina Ghorab
Ellen Miles
Alden Chesney
Matthew C. Cheung
Show All
Source
Cite
Save
Citations (0)
1